Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CI Stock Forecast 2026-2027
$276.69
Current Price
$73.91B
Market Cap
Buy 22
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to CI Price Targets
+36.6%
To High Target of $378.00
+21.6%
To Median Target of $336.50
+4.8%
To Low Target of $290.00
CI Price Momentum
+3.0%
1 Week Change
+5.3%
1 Month Change
-17.9%
1 Year Change
+0.5%
Year-to-Date Change
-20.9%
From 52W High of $350.00
+15.5%
From 52W Low of $239.51
📊 TOP ANALYST CALLS
Did CI Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Cigna is one of their latest high-conviction picks.
Latest CI Stock Price Targets & Analyst Predictions
Based on our analysis of 39 Wall Street analysts, CI has a bullish consensus with a median price target of $336.50 (ranging from $290.00 to $378.00). The overall analyst rating is Strong Buy (9.2/10). Currently trading at $276.69, the median forecast implies a 21.6% upside. This outlook is supported by 22 Buy, 2 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Scott Fidel at Stephens & Co., suggesting a 4.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CI Analyst Ratings
22
Buy
2
Hold
0
Sell
CI Price Target Range
Low
$290.00
Average
$336.50
High
$378.00
Current: $276.69
Latest CI Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CI.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 12, 2026 | Bernstein | Lance Wilkes | Outperform | Upgrade | $358.00 |
| Mar 3, 2026 | Piper Sandler | Jessica Tassan | Overweight | Reiterates | $370.00 |
| Feb 17, 2026 | Truist Securities | David Macdonald | Buy | Reiterates | $350.00 |
| Feb 9, 2026 | TD Cowen | Charles Rhyee | Buy | Maintains | $338.00 |
| Feb 6, 2026 | Barclays | Andrew Mok | Overweight | Maintains | $303.00 |
| Feb 6, 2026 | RBC Capital | Ben Hendrix | Outperform | Maintains | $333.00 |
| Feb 6, 2026 | Guggenheim | Jason Cassorla | Buy | Maintains | $334.00 |
| Feb 2, 2026 | Guggenheim | Jason Cassorla | Buy | Reiterates | $318.00 |
| Jan 5, 2026 | Barclays | Andrew Mok | Overweight | Maintains | $305.00 |
| Jan 5, 2026 | Truist Securities | David Macdonald | Buy | Maintains | $320.00 |
| Nov 12, 2025 | Bernstein | Lance Wilkes | Market Perform | Maintains | $294.00 |
| Nov 5, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $300.00 |
| Nov 4, 2025 | TD Cowen | Charles Rhyee | Buy | Maintains | $333.00 |
| Nov 4, 2025 | Goldman Sachs | Scott Fidel | Buy | Maintains | $330.00 |
| Nov 4, 2025 | JP Morgan | Lisa Gill | Overweight | Maintains | $375.00 |
| Nov 3, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $300.00 |
| Oct 14, 2025 | Goldman Sachs | Scott Fidel | Buy | Initiates | $370.00 |
| Oct 7, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $354.00 |
| Sep 4, 2025 | Barclays | Andrew Mok | Overweight | Maintains | $383.00 |
| Aug 26, 2025 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $365.00 |
The Cigna Group (CI) Competitors
The following stocks are similar to Cigna based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
The Cigna Group (CI) Financial Data
The Cigna Group has a market capitalization of $73.91B with a P/E ratio of 12.6x. The company generates $274.90B in trailing twelve-month revenue with a 2.2% profit margin.
Revenue growth is +10.4% quarter-over-quarter, while maintaining an operating margin of +3.5% and return on equity of +15.1%.
Valuation Metrics
Market Cap
$73.91B
Enterprise Value
$96.32B
P/E Ratio
12.6x
PEG Ratio
-1.3x
Price/Sales
0.3x
Growth & Margins
Revenue Growth (YoY)
+10.4%
Gross Margin
N/A
Operating Margin
+3.5%
Net Margin
+2.2%
EPS Growth
-13.3%
Financial Health
Cash/Price Ratio
+12.0%
Current Ratio
0.8x
Debt/Equity
75.1x
ROE
+15.1%
ROA
+4.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
The Cigna Group (CI) Business Model
About The Cigna Group
What They Do
Provides global health insurance and services.
Business Model
The company operates through various segments, including Evernorth Health Services and Cigna Healthcare, offering a wide array of insurance products such as medical, dental, and pharmacy benefits. It generates revenue by partnering with health plans, employers, and government organizations to deliver integrated health solutions, manage pharmacy benefits, and provide coordinated healthcare services.
Additional Information
Founded in 1792 and headquartered in Bloomfield, Connecticut, the organization serves clients in the U.S. and international markets, leveraging data-driven care management and digital health tools to enhance patient outcomes and cost efficiency.
Company Information
Sector
Healthcare
Industry
Healthcare Plans
Employees
65,669
CEO
Mr. David Michael Cordani
Country
United States
IPO Year
1982
Website
www.thecignagroup.comThe Cigna Group (CI) Latest News & Analysis
Latest News
Quick Summary
The Cigna Group Foundation is expanding its Impact Fund to Memphis, offering two-year grants to nonprofits for health-related community solutions. Applications are open until May 15.
Why It Matters
Cigna Group's expansion of its Impact Fund indicates increased community investment, potentially enhancing its brand reputation and customer loyalty, which can positively influence stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Cigna Healthcare Once Again Recognized for Industry Leading Digital Experience by JD Power
7 days ago
Quick Summary
Cigna Healthcare (NYSE: CI) received top rankings for digital satisfaction, reflecting its investment in AI-powered tools for better management of health care coverage.
Why It Matters
Cigna's high customer satisfaction reflects successful investments in AI tools, potentially leading to increased customer retention and revenue growth, positively impacting its stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
US managed care insurers' stocks rose after CMS announced a 2.48% average rate increase for Medicare Advantage in 2027, adding over $13 billion in payments.
Why It Matters
Higher Medicare Advantage rates boost revenue prospects for managed care insurers, enhancing profitability and stock performance, signaling a positive outlook for the sector.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Cigna Group (CI) is rated a Buy, with projected double-digit EPS growth from 2027. Key drivers include pharmacy segment growth and share buybacks. Shares are 29% undervalued, with a 17% total return forecasted through 2031.
Why It Matters
Cigna's strong growth prospects in income per share, competitive valuation, and strategic initiatives position it for significant returns, making it an attractive investment opportunity.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Cigna Group (NYSE:CI) will release Q1 2026 financial results on April 30, 2026, and will hold a conference call on the same day.
Why It Matters
Cigna's upcoming financial results and conference call may impact its stock price, reflecting market expectations and influencing investor sentiment in the healthcare sector.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Cigna (CI) has a strong earnings surprise history and is positioned well for a potential earnings beat in its upcoming quarterly report.
Why It Matters
Cigna's strong earnings surprise history and favorable conditions suggest potential for positive stock price movement, indicating a good opportunity for investors to capitalize on upcoming performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About CI Stock
What is The Cigna Group's (CI) stock forecast for 2026?
Based on our analysis of 39 Wall Street analysts, The Cigna Group (CI) has a median price target of $336.50. The highest price target is $378.00 and the lowest is $290.00.
Is CI stock a good investment in 2026?
According to current analyst ratings, CI has 22 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $276.69. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CI stock?
Wall Street analysts predict CI stock could reach $336.50 in the next 12 months. This represents a 21.6% increase from the current price of $276.69. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is The Cigna Group's business model?
The company operates through various segments, including Evernorth Health Services and Cigna Healthcare, offering a wide array of insurance products such as medical, dental, and pharmacy benefits. It generates revenue by partnering with health plans, employers, and government organizations to deliver integrated health solutions, manage pharmacy benefits, and provide coordinated healthcare services.
What is the highest forecasted price for CI The Cigna Group?
The highest price target for CI is $378.00 from at , which represents a 36.6% increase from the current price of $276.69.
What is the lowest forecasted price for CI The Cigna Group?
The lowest price target for CI is $290.00 from Scott Fidel at Stephens & Co., which represents a 4.8% increase from the current price of $276.69.
What is the overall CI consensus from analysts for The Cigna Group?
The overall analyst consensus for CI is bullish. Out of 39 Wall Street analysts, 22 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $336.50.
How accurate are CI stock price projections?
Stock price projections, including those for The Cigna Group, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 22, 2026 6:27 AM UTC